SEC Form 4 research
| Issuer | Actinium Pharmaceuticals, Inc. |
|---|---|
| Tickers | CTVN, ATNM |
| Reporting owners | 24 |
| Officers and directors | 11 |
| Last public filing | 2026-09-05 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-04 | 2026-09-02 | Nicholson, C. David | A | 62,800 | $0 | Not reported |
| 2026-09-04 | 2026-09-02 | Nicholson, C. David | A | 94,200 | $0 | Not reported |
| 2026-09-04 | 2026-09-02 | Shetty Ajit | A | 61,600 | $0 | Not reported |
| 2026-09-04 | 2026-09-02 | Shetty Ajit | A | 92,400 | $0 | Not reported |
| 2026-09-04 | 2026-09-02 | Almenoff June Sherie | A | 18,000 | $0 | Not reported |
| 2026-09-04 | 2026-09-02 | Almenoff June Sherie | A | 27,000 | $0 | Not reported |
| 2026-09-04 | 2026-09-02 | SETH SANDESH | A | 1,027,274 | $0 | Not reported |
| 2026-09-04 | 2026-09-02 | SETH SANDESH | A | 753,600 | $0 | Not reported |
| 2026-09-04 | 2026-09-02 | SETH SANDESH | A | 1,130,400 | $0 | Not reported |
| 2026-09-04 | 2026-09-02 | Steinhart Richard I | A | 62,800 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.